Literature DB >> 8565753

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

H C Pinto1, A Baptista, M E Camilo, A Valente, A Saragoça, M C de Moura.   

Abstract

This study reports a clinicopathological analysis of 105 patients whose liver histology showed a pattern of alcohol-like steatohepatitis. There were 32 nonalcoholic, 21 asymptomatic ambulatory, and 52 hospitalized alcoholic hepatitis patients. Female sex, obesity, and diabetes predominated in nonalcoholics. Clinical and laboratory presentation were similar in nonalcoholics and ambulatory alcoholics, but different from the hospitalized alcoholics. Histology showed an increasing degree of severity of hepatocellular damage, Mallory bodies, neutrophil and mononuclear infiltration, and pericellular and portal fibrosis from the nonalcoholics to the hospitalized alcoholics, with ambulatory alcoholics displaying an intermediate degree of severity. Steatosis and glycogenated nuclei were prevalent in the obese, diabetic nonalcoholics, of whom 47% had significant fibrosis and 8% cirrhosis, the latter present in 38% and 89% of ambulatory and hospitalized alcoholic hepatitis (P = 0.0001), respectively. In asymptomatic subjects with suspected liver disease, a liver biopsy is the only way of establishing the type and severity of liver lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8565753     DOI: 10.1007/bf02208601

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Hepatitis C virus does not cause nonalcoholic steatohepatitis.

Authors:  D W Rogers; C H Lee; D C Pound; S Kumar; O W Cummings; L Lumeng
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

2.  Liver disease of the alcoholic.

Authors:  C M Leevy; C H Tamburro; R Zetterman
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

Review 3.  [The liver and obesity].

Authors:  A Braillon; J P Capron
Journal:  Gastroenterol Clin Biol       Date:  1983 Jun-Jul

4.  Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth.

Authors:  M Nazim; G Stamp; H J Hodgson
Journal:  Hepatogastroenterology       Date:  1989-10

5.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

6.  A prospective study of alcoholic liver disease and mortality.

Authors:  I A Bouchier; W S Hislop; R J Prescott
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

7.  Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting.

Authors:  E B Keeffe; P W Adesman; P Stenzel; R M Palmer
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

8.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  38 in total

Review 1.  Mallory-Denk Bodies in chronic hepatitis.

Authors:  Metin Basaranoglu; Nesrin Turhan; Abdullah Sonsuz; Gökcen Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

Review 2.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 3.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 4.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

5.  Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.

Authors:  Tomislav Bulum; Branko Kolarić; Lea Duvnjak; Marko Duvnjak
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.199

6.  Cost-utility analysis of nonalcoholic steatohepatitis screening.

Authors:  Eric Zhang; Claire Wartelle-Bladou; Luigi Lepanto; Jean Lachaine; Guy Cloutier; An Tang
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

Review 7.  Evolving pathophysiologic concepts in nonalcoholic steatohepatitis.

Authors:  Brent A Neuschwander-Tetri
Journal:  Curr Gastroenterol Rep       Date:  2002-02

8.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity.

Authors:  Rushad Patell; Rupal Dosi; Harshal Joshi; Smit Sheth; Purav Shah; Sarfaraz Jasdanwala
Journal:  J Clin Diagn Res       Date:  2013-01-12

Review 9.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

Review 10.  Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.